Informations:
Erreur:
ID
27816
Description
A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection; ODM derived from: https://clinicaltrials.gov/show/NCT00605384
Lien
https://clinicaltrials.gov/show/NCT00605384
Mots-clés
Versions (1)
- 30/11/2017 30/11/2017 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
30 novembre 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Chronic Hepatitis B NCT00605384
Eligibility Chronic Hepatitis B NCT00605384
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Hepatitis B NCT00605384
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Hepatitis B, Chronic
Item
chronic hbv infection
boolean
C0524909 (UMLS CUI [1])
Lamivudine | Lamivudine Resistance
Item
history of lamivudine (lvd) treatment, and lamivudine resistance (lvdr), receiving lvd at screening visit
boolean
C0209738 (UMLS CUI [1])
C0209738 (UMLS CUI [2,1])
C1514892 (UMLS CUI [2,2])
C0209738 (UMLS CUI [2,1])
C1514892 (UMLS CUI [2,2])
Liver function Compensated
Item
compensated liver function
boolean
C0232741 (UMLS CUI [1,1])
C0205432 (UMLS CUI [1,2])
C0205432 (UMLS CUI [1,2])
Hepatitis B DNA Measurement
Item
hbv dna ≥ 172,000 iu/ml
boolean
C3641250 (UMLS CUI [1])
Hepatitis B e antigen positive | Hepatitis B e antigen negative
Item
hepatitis b e-antigen (hbeag)-positive or hbeag-negative
boolean
C0392390 (UMLS CUI [1])
C0948827 (UMLS CUI [2])
C0948827 (UMLS CUI [2])
Decompensated cirrhosis
Item
evidence of decompensated cirrhosis
boolean
C1619727 (UMLS CUI [1])
HIV coinfection | HCV coinfection | HDV Coinfection
Item
coinfection with human immunodeficiency virus (hiv), hepatitis c virus (hcv), or hepatitis d virus (hdv)
boolean
C4062778 (UMLS CUI [1])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
Pancreatitis
Item
recent history of pancreatitis
boolean
C0030305 (UMLS CUI [1])
serum alpha-fetoprotein measurement
Item
serum alpha fetoprotein > 100 ng/ml
boolean
C0546833 (UMLS CUI [1])
Exception Lamivudine | Nucleoside Analogs Antiviral Agents Against Hepatitis B | Nucleotide analog Antiviral Agents Against Hepatitis B
Item
except lamivudine, any prior therapy with nucleoside or nucleotide analogue antiviral agents with activity against hepatitis b
boolean
C1705847 (UMLS CUI [1,1])
C0209738 (UMLS CUI [1,2])
C1579410 (UMLS CUI [2,1])
C0003451 (UMLS CUI [2,2])
C0521124 (UMLS CUI [2,3])
C0019163 (UMLS CUI [2,4])
C0597107 (UMLS CUI [3,1])
C0003451 (UMLS CUI [3,2])
C0521124 (UMLS CUI [3,3])
C0019163 (UMLS CUI [3,4])
C0209738 (UMLS CUI [1,2])
C1579410 (UMLS CUI [2,1])
C0003451 (UMLS CUI [2,2])
C0521124 (UMLS CUI [2,3])
C0019163 (UMLS CUI [2,4])
C0597107 (UMLS CUI [3,1])
C0003451 (UMLS CUI [3,2])
C0521124 (UMLS CUI [3,3])
C0019163 (UMLS CUI [3,4])